ClinVar Genomic variation as it relates to human health
NM_000214.3(JAG1):c.551G>A (p.Arg184His)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000214.3(JAG1):c.551G>A (p.Arg184His)
Variation ID: 7620 Accession: VCV000007620.15
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 20p12.2 20: 10658611 (GRCh38) [ NCBI UCSC ] 20: 10639259 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 6, 2017 Apr 6, 2024 Mar 29, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000214.3:c.551G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000205.1:p.Arg184His missense NC_000020.11:g.10658611C>T NC_000020.10:g.10639259C>T NG_007496.1:g.20436G>A LRG_1191:g.20436G>A LRG_1191t1:c.551G>A LRG_1191p1:p.Arg184His P78504:p.Arg184His - Protein change
- R184H
- Other names
- -
- Canonical SPDI
- NC_000020.11:10658610:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
JAG1 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
1843 | 1887 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Mar 29, 2024 | RCV000008059.24 | |
Pathogenic (1) |
criteria provided, single submitter
|
Apr 7, 2017 | RCV000725979.11 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 12, 2021 | RCV002476943.8 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Apr 07, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000340966.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 4
Sex: mixed
|
|
Pathogenic
(Jul 12, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Alagille syndrome due to a JAG1 point mutation
Tetralogy of Fallot Deafness, congenital heart defects, and posterior embryotoxon Charcot-Marie-Tooth disease, axonal, Type 2HH
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000894216.2
First in ClinVar: Mar 31, 2019 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Mar 29, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Alagille syndrome due to a JAG1 point mutation
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004807839.1
First in ClinVar: Apr 06, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(Feb 04, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Alagille syndrome due to a JAG1 point mutation
Affected status: yes
Allele origin:
unknown
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV002102428.1
First in ClinVar: Mar 05, 2022 Last updated: Mar 05, 2022 |
Comment:
_x000D_ Criteria applied: PS3, PM5_STR, PS4_MOD, PM2_SUP, PP2, PP3
|
|
Pathogenic
(Jul 13, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Alagille syndrome due to a JAG1 point mutation
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000829372.4
First in ClinVar: Oct 10, 2018 Last updated: Feb 20, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg184 amino acid residue in JAG1. Other variant(s) that disrupt this … (more)
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg184 amino acid residue in JAG1. Other variant(s) that disrupt this residue have been observed in individuals with JAG1-related conditions (PMID: 10220506, 10533065), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change affects JAG1 function (PMID: 11058898, 22487239). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt JAG1 protein function. ClinVar contains an entry for this variant (Variation ID: 7620). This missense change has been observed in individuals with Alagille syndrome (PMID: 9585603, 10220506, 12442286, 24748328, 25676721). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 184 of the JAG1 protein (p.Arg184His). (less)
|
|
Pathogenic
(Feb 15, 2001)
|
no assertion criteria provided
Method: literature only
|
ALAGILLE SYNDROME 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000028264.2
First in ClinVar: Apr 04, 2013 Last updated: Jan 06, 2017 |
Comment on evidence:
See 601920.0005 and Krantz et al. (1998). In 2 assays of JAG1 function, Morrissette et al. (2001) found that the R184H mutation was associated with … (more)
See 601920.0005 and Krantz et al. (1998). In 2 assays of JAG1 function, Morrissette et al. (2001) found that the R184H mutation was associated with loss of Notch signaling activity relative to wildtype JAG1. The protein containing the R184H substitution was not present on the cell surface, was abnormally glycosylated, and appeared to be abnormally accumulated, possibly in the endoplasmic reticulum. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Alagille syndrome due to a JAG1 point mutation
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV001167335.2
First in ClinVar: Mar 09, 2020 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Alagille Syndrome. | Adam MP | - | 2024 | PMID: 20301450 |
Clinical features, outcomes, and genetic analysis in Korean children with Alagille syndrome. | Cho JM | Pediatrics international : official journal of the Japan Pediatric Society | 2015 | PMID: 25676721 |
Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome. | Jurkiewicz D | Journal of applied genetics | 2014 | PMID: 24748328 |
Functional analysis of the Notch ligand Jagged1 missense mutant proteins underlying Alagille syndrome. | Tada M | The FEBS journal | 2012 | PMID: 22487239 |
DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations in Australian alagille syndrome patients. | Heritage ML | Human mutation | 2002 | PMID: 12442286 |
Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome. | Morrissette JD | Human molecular genetics | 2001 | PMID: 11157803 |
Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome population. | Heritage ML | Human mutation | 2000 | PMID: 11058898 |
Jagged-1 mutation analysis in Italian Alagille syndrome patients. | Pilia G | Human mutation | 1999 | PMID: 10533065 |
Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. | Crosnier C | Gastroenterology | 1999 | PMID: 10220506 |
Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. | Krantz ID | American journal of human genetics | 1998 | PMID: 9585603 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=JAG1 | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs121918351 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.